Status:
NOT_YET_RECRUITING
Deep Neck Flexor Exercises Versus Myofascial Release of Suboccipital Muscles in Chronic Tension-type Headache
Lead Sponsor:
Iran University of Medical Sciences
Conditions:
Chronic Tension-Type Headache
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
According to the study of the burden of diseases in 2018, tension-type headache(TTH) is the most common type of primary headache and ranks third in terms of prevalence among 328 diseases and injuries ...
Detailed Description
Previous studies demonstrated that suboccipital active Trigger Points(TrPs) and forward head posture were associated with Chronic Tension-Type Headache(CTTH) and they can aggravate parameters of heada...
Eligibility Criteria
Inclusion
- Age between 18 and 55 years;
- based on ICHD-3, Headache that occurs 15 days per month and lasts on average for \>3 months (180 days per year), lasting hours to days, or unremitting, and has at least two of the following four characteristics recognized as CTTH: bilateral location, pressing or tightening (non-pulsating) quality, mild or moderate intensity, not aggravated by routine physical activity such as walking or climbing stairs and both of the following: no more than one of photophobia, phonophobia or mild nausea, neither moderate or severe nausea nor vomiting;
- Dosage and type of prophylactic medication have not changed in the months before the beginning of the trial;
- The participant does not intend to change the dosage and type of prophylactic medication during the study;
- CVA less than 49 degrees,
- Participants have the ability to understand and read Persian to complete the questionnaire.
Exclusion
- Participants with infrequent ETTH, or other primary or secondary types of headache;
- Pain aggravated by movement of the head;
- Severe pain or significant decrease in ROM of the cervical spine;
- Previous trauma to the cervical spine;
- History of injection, surgery, severe disc protrusion, or neck or shoulder fracture that affects treatment;
- Metabolic or Neurological disorders such as Bow hunter's syndrome or epilepsy;
- Taking more than 200 pieces of morphine or other strong analgesics per month;
- Physiotherapy treatment for headache within 6 months before starting treatment;
- Joint stiffness, atherosclerosis, or advanced osteoarthritis;
- Manual contraindication includes: (a)The participant has substance or alcohol abuse; (b)For whatever reason, the participant does not want to be touched by the therapist; (c)Symptoms are severe and irritating; (d)Underlying diseases (such as rheumatoid arthritis) or metabolic disorders (such as osteoporosis or soft tissue laxity of the treatment area);
- Pregnancy;
- Spielberger State-Trait Anxiety Inventory (STAI) scores more than 85;
- Absence of two consecutive sessions and more than treatment sessions.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05383365
Start Date
November 1 2024
End Date
December 1 2026
Last Update
October 1 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.